PRIORIX
PRIORIX
Approved
DIN Number
02239208
Drug Class
Human
Market Date
Dec 4, 1998
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02239208
AIG Number0431514004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BD52 MEASLES, COMBIN. WITH MUMPS AND RUBELLA, LIVE ATTENUATED
Product Specifications
Dosage FormKit
,
Powder For Solution
Route of AdministrationIntramuscular
,
Subcutaneous
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (4)
MEASLES VIRUS VACCINE LIVE ATTENUATEDActive
Strength: 1000 CCID50 / 0.5 ML
Monograph: MEASLES VIRUS VACCINE LIVE ATTENUATED
MUMPS VIRUS VACCINE LIVE ATTENUATED (JERYL LYNN STRAIN)Active
Strength: 10000 CCID50 / 0.5 ML
Monograph: MUMPS VIRUS VACCINE LIVE ATTENUATED (JERYL LYNN STRAIN)
RUBELLA VIRUS VACCINE LIVE ATTENUATED (WISTAR RA27/3 STRAIN)Active
Strength: 1000 CCID50 / 0.5 ML
Monograph: RUBELLA VIRUS VACCINE LIVE ATTENUATED (WISTAR RA27/3 STRAIN)
WATERActive
Strength: 0.5 ML
Monograph: WATER